We are Driven by Accomplishment
AngioGenex leverages top talent and leading scientific experts including life sciences industry veterans with proven experience advancing novel pharmaceutical products. Our scientific advisors come from top medical institutions and bring strong working knowledge of cancer biology and angiogenesis.
We Collaborate with Industry Leaders
We believe that breakthrough science requires collaboration. We have collaborated with leading academics, research institutions, and charitable organizations to discover and develop therapies for important unmet medical needs.
Unlocking the Vast Potential
of Id Protein Inhibitors
AngioGenex and its collaborators, including Robert Benezra, Ph.D., and The Robert Benezra Lab at Sloan Kettering Institute, have assembled key platform enabling technologies and tools that allow for the identification of specific and potent small molecule binders of Id, a key mediator of both tumor progression and spread as well as new blood vessel formation (angiogenesis).